


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
HOLX
Hologic
$75.00
Strengths

Earnings are forecast to grow

Investors confidence is positive

Trading below its fair value
HOLX Price Performance
$74.14 (+1.16%)
$66.33 (+13.07%)
$66.1 (+13.46%)
$72.6 (+3.31%)
HOLX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

HOLX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
HOLX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HOLX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is HOLX current stock price?
What are HOLX stock strengths?
What is HOLX Risk Level?
What is HOLX market cap and volume?
What is HOLX current Stock IQ?
Should I buy HOLX stock right now?
Is HOLX a Strong Buy right now?
What does a 'Strong Buy' rating mean for HOLX?
What does a 'Strong Sell' rating mean for HOLX?
What factors influence HOLX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
HOLX
Hologic
Current Price
$75.00
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive

Trading below its fair value

HOLX Price Performance
$74.14 (+1.16%)
$66.33 (+13.07%)
$66.1 (+13.46%)
$72.6 (+3.31%)
HOLX Analysts Opinion
HOLX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
HOLX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HOLX Street Sentiment is extremely bullish and have positive views on the near-term outlook
HOLX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
HOLX Stock IQ
HOLX Latest Analysis
What Is Driving Hologics Strength in the US Diagnostics Market?. HOLXs Diagnostics gains accelerate as United States molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.
Fri Dec 12, 2025
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?. Hologic shares rise 16% in six months with divisional strength clinical data and a go-private deal shaping the short-term outlook.
Mon Dec 8, 2025
Hologics BCI Test Shows Growing Impact in Endocrine Therapy Decisions. HOLXs BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
Thu Dec 4, 2025
Hologic Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It. Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So it is worth exploring what lies ahead for the stock.
Mon Dec 1, 2025
VNRX: 3Q 2025 results reported. Revenues & EPS above our expectations. cost cutting very evident. At least seven major operational milestones have been achieved thus far in 2025.. By EXECUTIVE SUMMARYVolitionRxs (NYSE:VNRX): Managements Within the In late-November 2025 Volition announced that In 3Q 2025 Volition reported total revenues of $627277 up 32.2% year-over-year and 54.2% sequentially. Product revenues increased 32.6% year-over-year to $538381 and 120% sequentially primarily from Nu.Q Ve
Mon Dec 1, 2025
Heres Why Hologic (HOLX) is a Strong Value Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Wed Nov 26, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HOLX Stock trends
HOLX Stock performance
HOLX Stock analysis
HOLX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.